Baird Maintains Neutral on Genpact, Lowers Price Target to $38

Benzinga Newsdesk www.benzinga.com Negative 79.9%

Neg 79.9% Neu 0% Pos 0%

Baird analyst David Koning maintains Genpact (NYSE:G) with a Neutral and lowers the price target from $45 to $38.

Comments

No comments yet. Be the first!